According to GuruFocus updates, these Guru stocks have reached their 52-Week Highs: BristolMyers Squibb Company (BMY, Financial), Mead Johnson Nutrition Company (MJN, Financial), Equity Residential (EQR, Financial), PG&E Corp. (PCG, Financial), and Spectra Energy Corp. (SE, Financial).
BristolMyers Squibb Company (BMY) Reached the 52-Week High of $27.16
Bristol-Myers Squibb Company is a global leader in the research and development of innovative lifesaving and life-enhancing treatments for heart disease; high blood pressure; stroke; diabetes; cancer; HIV/AIDS and other infectious diseases; depression, schizophrenia and other mental disorders; pain; and other conditions. Bristolmyers Squibb Company has a market cap of $46.58 billion; its shares were traded at around $27.16 with a P/E ratio of 13 and P/S ratio of 2.4. The dividend yield of Bristolmyers Squibb Company stocks is 4.7%. Bristolmyers Squibb Company had an annual average earning growth of 3.3% over the past 5 years.
On July 22, Bristol-Myers Squibb posted second quarter 2010 net sales of $4.8 billion, an increase of 2% compared to the same period in 2009. U.S. Health care reform had a 1.5% negative effect on net sales in the second quarter. U.S. net sales increased 4% to $3.1 billion in the second quarter of 2010 compared to the same period in 2009. International net sales decreased 2%, or 3% excluding foreign exchange impact, to $1.7 billion.
BristolMyers Squibb Company is in the portfolios of Irving Kahn, James Barrow, Mewhinney & Strauss, Bill Nygren, David Williams, Charles Brandes, Edward Owens, HOTCHKIS & WILEY, Brian Rogers, John Buckingham, Jeremy Grantham, Pioneer Investments, Bill Frels, Mairo Gabelli, Louis Moore Bacon, Diamond Hill Capital, Murray Stahl, Dodge & Cox, Prem Watsa, David Dreman, Ruane Cunniff, Jean-Marie Eveillard, Kenneth Fisher, and Steven Cohen.
Last month, Sell: SVP HR Public Affairs & Philan John E Celentano and Sell: VP & Financial Controller Joseph C Caldarella sold shares of BMY stock.
Mead Johnson Nutrition Company (MJN) Reached the 52-Week High of $56.5
Mead Johnson Nutrition Company is a pediatric nutrition company. Mead Johnson Nutrition Company has a market cap of $11.56 billion; its shares were traded at around $56.5 with a P/E ratio of 24.5 and P/S ratio of 4. The dividend yield of Mead Johnson Nutriti stocks is 1.6%.
Mead Johnson Nutrition Company is in the portfolios of Daniel Loeb, Steve Mandel, Paul Tudor Jones, Stanley Druckenmiller, David Winters, John Paulson, Chris Davis, Eric Mindich, Edward Owens, Mario Gabelli, George Soros, Jim Simons, Steven Cohen, Murray Stahl, and Jeremy Grantham.
Buy: Sr. VP and CFO Peter G Leemputte bought 200 shares of MJN stock on in May; Buy: Director James M Cornelius bought 10,000 shares in August.
Equity Residential (EQR) Reached the 52-Week High of $48.63
Equity Residential Prop. is a self-administered and self-managed equity real estate investment trust. Equity Residential has a market cap of $13.78 billion; its shares were traded at around $48.63 with a P/E ratio of 23.1 and P/S ratio of 7.1. The dividend yield of Equity Residential stocks is 2.8%. Equity Residential had an annual average earning growth of 3.2% over the past 5 years.
On July 28, Equity Residential reported results for the second quarter of 2010. The company reported earnings of $0.02 per share compared to the pre-impairment $0.39 per share in the second quarter of 2009. The difference is due primarily to lower gains from property sales in 2010. FFO for the quarter ended June 30, 2010 was $0.58 per share compared to the pre impairment $0.62 per share for the same period of 2009.
Equity Residential is in the portfolios of Ken Heebner, Andreas Halvorsen, Pioneer Investments, Bruce Koyner, Paul Tudor Jones, Jeremy Grantham, Steven Cohen, Manning & Napier Advisors Inc., Dodge & Cox, and Chris Davis.
Last month, Sell: President & CEO David J Neithercut, Sell: Executive Vice President & CFO Mark J. Parrell, Sell: EVP & General Counsel Bruce C Strohm, and Sell: Chief Accounting Officer Ian Kaufman, and Sell: EVP & General Counsel Bruce C Strohm sold shares of EQR stock.
PG&E Corp. (PCG) Reached the 52-Week High of $46.78
PG&E Corporation is an energy-based holding company. Pg&e Corp. has a market cap of $18.28 billion; its shares were traded at around $46.78 with a P/E ratio of 13.6 and P/S ratio of 1.3. The dividend yield of Pg&e Corp. stocks is 3.9%. Pg&e Corp. had an annual average earning growth of 3.1% over the past 5 years.
On August 4, PG&E Corporation reported net income was $333 million, or $0.86 per share, in the second quarter ended June 30, 2010, as reported in accordance with generally accepted accounting principles (GAAP). This compares with $388 million, or $1.02 per share in the same period last year, which included $0.19 per share reflecting the net positive impact of one-time items.
PG&E Corp. is in the portfolios of Brian Rogers, Jim Simons, Pioneer Investments, Prem Watsa, and George Soros.
Sell: VP and Controller Dinyar B Mistry sold 7,712 shares of PCG stock last month.
Spectra Energy Corp (SE) Reached the 52-Week High of $23.45
Spectra Energy Corp. is one of North America's premier natural gas infrastructure companies serving three key links in the natural gas value chain: gathering and processing, transmission and storage, and distribution. Spectra Energy Corp has a market cap of $15.2 billion; its shares were traded at around $23.45 with a P/E ratio of 16.5 and P/S ratio of 3.3. The dividend yield of Spectra Energy Corp stocks is 4.2%.
On August 4, Spectra Energy Corp reported 2010 second quarter net income from controlling interests of $174 million, or $0.27 diluted EPS, compared with $140 million, or $0.22 diluted EPS, in the prior year quarter.
Spectra Energy Corp. is in the portfolios of James Barrow, Mewhinney & Strauss, Brion Rogers, John Buckingham, Pioneer Investments, Paul Tudor Jones, Bruce Koyner, Mario Gabelli, Richard Aster Jr, Steven Cohen, George Soros, Chris Davis, and Dodge & Cox.
Buy: Director Dennis R Hendrix bought 5,000 shares of SE stock in May. Sell: Director Paul M Anderson sold 30,000 shares last month and Sell: Vice President and Treasurer Stephen W Baker sold 424 shares in April.
BristolMyers Squibb Company (BMY) Reached the 52-Week High of $27.16
Bristol-Myers Squibb Company is a global leader in the research and development of innovative lifesaving and life-enhancing treatments for heart disease; high blood pressure; stroke; diabetes; cancer; HIV/AIDS and other infectious diseases; depression, schizophrenia and other mental disorders; pain; and other conditions. Bristolmyers Squibb Company has a market cap of $46.58 billion; its shares were traded at around $27.16 with a P/E ratio of 13 and P/S ratio of 2.4. The dividend yield of Bristolmyers Squibb Company stocks is 4.7%. Bristolmyers Squibb Company had an annual average earning growth of 3.3% over the past 5 years.
On July 22, Bristol-Myers Squibb posted second quarter 2010 net sales of $4.8 billion, an increase of 2% compared to the same period in 2009. U.S. Health care reform had a 1.5% negative effect on net sales in the second quarter. U.S. net sales increased 4% to $3.1 billion in the second quarter of 2010 compared to the same period in 2009. International net sales decreased 2%, or 3% excluding foreign exchange impact, to $1.7 billion.
BristolMyers Squibb Company is in the portfolios of Irving Kahn, James Barrow, Mewhinney & Strauss, Bill Nygren, David Williams, Charles Brandes, Edward Owens, HOTCHKIS & WILEY, Brian Rogers, John Buckingham, Jeremy Grantham, Pioneer Investments, Bill Frels, Mairo Gabelli, Louis Moore Bacon, Diamond Hill Capital, Murray Stahl, Dodge & Cox, Prem Watsa, David Dreman, Ruane Cunniff, Jean-Marie Eveillard, Kenneth Fisher, and Steven Cohen.
Last month, Sell: SVP HR Public Affairs & Philan John E Celentano and Sell: VP & Financial Controller Joseph C Caldarella sold shares of BMY stock.
Mead Johnson Nutrition Company (MJN) Reached the 52-Week High of $56.5
Mead Johnson Nutrition Company is a pediatric nutrition company. Mead Johnson Nutrition Company has a market cap of $11.56 billion; its shares were traded at around $56.5 with a P/E ratio of 24.5 and P/S ratio of 4. The dividend yield of Mead Johnson Nutriti stocks is 1.6%.
Mead Johnson Nutrition Company is in the portfolios of Daniel Loeb, Steve Mandel, Paul Tudor Jones, Stanley Druckenmiller, David Winters, John Paulson, Chris Davis, Eric Mindich, Edward Owens, Mario Gabelli, George Soros, Jim Simons, Steven Cohen, Murray Stahl, and Jeremy Grantham.
Buy: Sr. VP and CFO Peter G Leemputte bought 200 shares of MJN stock on in May; Buy: Director James M Cornelius bought 10,000 shares in August.
Equity Residential (EQR) Reached the 52-Week High of $48.63
Equity Residential Prop. is a self-administered and self-managed equity real estate investment trust. Equity Residential has a market cap of $13.78 billion; its shares were traded at around $48.63 with a P/E ratio of 23.1 and P/S ratio of 7.1. The dividend yield of Equity Residential stocks is 2.8%. Equity Residential had an annual average earning growth of 3.2% over the past 5 years.
On July 28, Equity Residential reported results for the second quarter of 2010. The company reported earnings of $0.02 per share compared to the pre-impairment $0.39 per share in the second quarter of 2009. The difference is due primarily to lower gains from property sales in 2010. FFO for the quarter ended June 30, 2010 was $0.58 per share compared to the pre impairment $0.62 per share for the same period of 2009.
Equity Residential is in the portfolios of Ken Heebner, Andreas Halvorsen, Pioneer Investments, Bruce Koyner, Paul Tudor Jones, Jeremy Grantham, Steven Cohen, Manning & Napier Advisors Inc., Dodge & Cox, and Chris Davis.
Last month, Sell: President & CEO David J Neithercut, Sell: Executive Vice President & CFO Mark J. Parrell, Sell: EVP & General Counsel Bruce C Strohm, and Sell: Chief Accounting Officer Ian Kaufman, and Sell: EVP & General Counsel Bruce C Strohm sold shares of EQR stock.
PG&E Corp. (PCG) Reached the 52-Week High of $46.78
PG&E Corporation is an energy-based holding company. Pg&e Corp. has a market cap of $18.28 billion; its shares were traded at around $46.78 with a P/E ratio of 13.6 and P/S ratio of 1.3. The dividend yield of Pg&e Corp. stocks is 3.9%. Pg&e Corp. had an annual average earning growth of 3.1% over the past 5 years.
On August 4, PG&E Corporation reported net income was $333 million, or $0.86 per share, in the second quarter ended June 30, 2010, as reported in accordance with generally accepted accounting principles (GAAP). This compares with $388 million, or $1.02 per share in the same period last year, which included $0.19 per share reflecting the net positive impact of one-time items.
PG&E Corp. is in the portfolios of Brian Rogers, Jim Simons, Pioneer Investments, Prem Watsa, and George Soros.
Sell: VP and Controller Dinyar B Mistry sold 7,712 shares of PCG stock last month.
Spectra Energy Corp (SE) Reached the 52-Week High of $23.45
Spectra Energy Corp. is one of North America's premier natural gas infrastructure companies serving three key links in the natural gas value chain: gathering and processing, transmission and storage, and distribution. Spectra Energy Corp has a market cap of $15.2 billion; its shares were traded at around $23.45 with a P/E ratio of 16.5 and P/S ratio of 3.3. The dividend yield of Spectra Energy Corp stocks is 4.2%.
On August 4, Spectra Energy Corp reported 2010 second quarter net income from controlling interests of $174 million, or $0.27 diluted EPS, compared with $140 million, or $0.22 diluted EPS, in the prior year quarter.
Spectra Energy Corp. is in the portfolios of James Barrow, Mewhinney & Strauss, Brion Rogers, John Buckingham, Pioneer Investments, Paul Tudor Jones, Bruce Koyner, Mario Gabelli, Richard Aster Jr, Steven Cohen, George Soros, Chris Davis, and Dodge & Cox.
Buy: Director Dennis R Hendrix bought 5,000 shares of SE stock in May. Sell: Director Paul M Anderson sold 30,000 shares last month and Sell: Vice President and Treasurer Stephen W Baker sold 424 shares in April.
